The laws, regulations, strategies, and governance frameworks that guide how governments and institutions address substance use, substance use disorders, and illicit drug trafficking. These policies shape coordinated responses across prevention, treatment, recovery support, public health, regulatory control, and law enforcement. Effective substance use policies aim to reduce health and social harms, ensure access to prevention and treatment services, regulate controlled substances, and disrupt illicit drug markets. They are typically informed by scientific evidence, public health principles, and cross-sector collaboration to promote safer and healthier communities.
Policy
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
New Psychoactive Substances (NPS): Black market and policy of new psychoactive substances in the Asia region
Jamaica to update national drug policy
Novel Psychoactive Substances: Policy, Economics and Drug Regulation
Emerging Trends in Drugs, Addictions, and Health
New psychoactive substances: A review and updates
UNODC Early Warning Advisory on New Psychoactive Substances
CND / CCPCJ Briefing for Newcomers in the NGO Community
The UNODC Secretariat of the Governing Bodies is inviting all interested NGOs to attend a briefing about the Commission on Narcotic Drugs (CND) and the Commission on Crime Prevention and Criminal Justice (CCPCJ).
Webinar for Civil Society: The World Drug Report 2022
Learn more about the newest trends regarding the World Drug Situation in this webinar for civi society. UNODC experts will present this year's World Drug Report 2022, giving an overview about the latest developments and diving into the newest available global data.
In the second part two civil society representatives will explain how they use the World Drug Report in their day-to-day work.
CND Special Event to commemorate World Drug Day including presentations on the World Drug Report.
The World Drug Report 2022 presents an overview of the current trends on global drug markets and includes the latest information on drug use, production, and trafficking.
It analyzes the gender gap relating to drug use and the impact of the COVID-19 pandemic.